Decibel Cannabis Company Inc
Decibel Cannabis Company Inc., an integrated cannabis company, engages in the cannabis cultivation in Canada. It is involved in the extraction, processing, and manufacturing of vape cartridges and glass tube packaging for pre-rolls. The company also engages in the business-to-business cannabis product sales in the provinces of Saskatchewan and Alberta; and e-commerce end-user customers in the pro… Read more
Decibel Cannabis Company Inc (DBCCF) - Net Assets
Latest net assets as of September 2025: $63.58 Million USD
Based on the latest financial reports, Decibel Cannabis Company Inc (DBCCF) has net assets worth $63.58 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($146.43 Million) and total liabilities ($82.85 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $63.58 Million |
| % of Total Assets | 43.42% |
| Annual Growth Rate | N/A |
| 5-Year Change | 93.58% |
| 10-Year Change | N/A |
| Growth Volatility | 10005.65 |
Decibel Cannabis Company Inc - Net Assets Trend (2016–2024)
This chart illustrates how Decibel Cannabis Company Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Decibel Cannabis Company Inc (2016–2024)
The table below shows the annual net assets of Decibel Cannabis Company Inc from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $64.72 Million | +40.09% |
| 2023-12-31 | $46.20 Million | -2.15% |
| 2022-12-31 | $47.21 Million | -6.95% |
| 2021-12-31 | $50.73 Million | +51.76% |
| 2020-12-31 | $33.43 Million | -16.18% |
| 2019-12-31 | $39.88 Million | -57.13% |
| 2018-12-31 | $93.03 Million | +28594.94% |
| 2018-07-31 | $324.19K | +523.63% |
| 2017-12-31 | $-76.53K | -35.62% |
| 2016-12-31 | $-56.43K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Decibel Cannabis Company Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 213241000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $79.43 Million | 122.74% |
| Total Equity | $64.72 Million | 100.00% |
Decibel Cannabis Company Inc Competitors by Market Cap
The table below lists competitors of Decibel Cannabis Company Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Astino Bhd
KLSE:7162
|
$18.01 Million |
|
Upsales Technology AB
ST:UPSALE
|
$18.02 Million |
|
Dotz Nano Limited
OTCQB:DTZZF
|
$18.02 Million |
|
NANOVIRICIDES NEW DL-01
F:NV3P
|
$18.03 Million |
|
Ma Kuang Healthcare Holding Ltd
TWO:4139
|
$18.00 Million |
|
Pardus Girisim Sermayesi Yatirim Ortakligi A.S.
IS:PRDGS
|
$18.00 Million |
|
BRAVE BISON GR.PLC LS-001
F:RT7
|
$18.00 Million |
|
DocCheck AG
XETRA:AJ91
|
$18.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Decibel Cannabis Company Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 46,196,000 to 64,715,000, a change of 18,519,000 (40.1%).
- Net income of 9,463,000 contributed positively to equity growth.
- Other factors increased equity by 9,056,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $9.46 Million | +14.62% |
| Other Changes | $9.06 Million | +13.99% |
| Total Change | $- | 40.09% |
Book Value vs Market Value Analysis
This analysis compares Decibel Cannabis Company Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.37x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.00 | $0.04 | x |
| 2017-12-31 | $-0.08 | $0.04 | x |
| 2018-07-31 | $0.00 | $0.04 | x |
| 2018-12-31 | $12.71 | $0.04 | x |
| 2019-12-31 | $0.12 | $0.04 | x |
| 2020-12-31 | $0.10 | $0.04 | x |
| 2021-12-31 | $0.13 | $0.04 | x |
| 2022-12-31 | $0.12 | $0.04 | x |
| 2023-12-31 | $0.11 | $0.04 | x |
| 2024-12-31 | $0.11 | $0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Decibel Cannabis Company Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.62%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.23%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 2.35x
- Recent ROE (14.62%) is above the historical average (-11.29%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.35K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-12.45K |
| 2018 | -58.24% | 0.00% | 0.00x | 1.31x | $-221.23K |
| 2018 | -15.48% | 0.00% | 0.00x | 2.32x | $-11.81 Million |
| 2019 | -16.37% | -104.75% | 0.07x | 2.22x | $-10.52 Million |
| 2020 | -27.55% | -30.77% | 0.34x | 2.65x | $-12.55 Million |
| 2021 | 3.44% | 3.32% | 0.42x | 2.48x | $-3.33 Million |
| 2022 | -9.45% | -5.62% | 0.56x | 2.98x | $-9.18 Million |
| 2023 | -3.83% | -1.67% | 0.74x | 3.10x | $-6.39 Million |
| 2024 | 14.62% | 10.23% | 0.61x | 2.35x | $2.99 Million |
Industry Comparison
This section compares Decibel Cannabis Company Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Decibel Cannabis Company Inc (DBCCF) | $63.58 Million | 0.00% | 1.30x | $18.01 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |